SemiLEDs Corporation (NASDAQ:LEDS) shares moved down -9.76% in last trading session and ended the day at $2.59. LEDS Gross Margin is -28.20% and its has a return on assets of -31.30%. SemiLEDs Corporation (NASDAQ:LEDS) quarterly performance is 564.10%.
On 12 April, SemiLEDs Corporation (NASDAQ:LEDS) reported that, Revenue for the second quarter of fiscal 2016 was $2.9 million, a 2% decrease compared to $3.0 million in the first quarter of fiscal 2016. GAAP net loss attributable to SemiLEDs stockholders for the second quarter of fiscal 2016 was $2.5 million, or a net loss of $0.09 per diluted share, compared to a loss of $3.3 million, or a net loss of $0.11 per diluted share for the first quarter of fiscal 2016.
Dover Downs Gaming & Entertainment Inc. (NYSE:DDE) ended the last trading day at $1.07. Company weekly volatility is calculated as 3.11% and price to cash ratio as 3.43. Dover Downs Gaming & Entertainment Inc. (NYSE:DDE) showed a weekly performance of -0.01%.
Dover Downs Gaming & Entertainment Inc. (NYSE:DDE) announced that it has regained compliance with the New York Stock Exchange’s share price continued listing standard.
On 20 April, USA Truck Inc. (NASDAQ:USAK) shares moved up 0.79% and was closed at $17.85. USAK EPS growth in last 5 year was 39.70%. USA Truck Inc. (NASDAQ:USAK) year to date (YTD) performance is 2.29%.
USA Truck Inc. (NASDAQ:USAK) announced it will release its first-quarter 2016 financial results at 6:00 a.m. CT / 7:00 a.m. ET on Thursday, May 5, 2016. The Company will hold a conference call to discuss those results at 8:00 a.m. CT / 9:00 a.m. ET that same day.
Atara Biotherapeutics, Inc. (NASDAQ:ATRA) shares moved up 0.88% in last trading session and ended the day at $20.68. ATRA has a return on assets of -23.00%. Atara Biotherapeutics, Inc. (NASDAQ:ATRA) quarterly performance is 3.50%.
Atara Biotherapeutics (NASDAQ:ATRA) said collaborating investigators at QIMR Berghofer Medical Research Institute presented positive phase one clinical data for T cell immunotherapy in nasopharyngeal cancer.
Spark Therapeutics, Inc. (NASDAQ:ONCE) caters to the Healthcare space. Its weekly performance is 7.49%. On the last day of trading company shares ended up at $37.73. Spark Therapeutics, Inc. (NASDAQ:ONCE) distance from 50-day simple moving average (SMA50) is 6.56%.
Spark Therapeutics Inc (NASDAQ:ONCE) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research note issued on Wednesday, Analyst Ratings Net reports. The firm presently has a $40.00 price objective on the stock. Zacks Investment Research‘s target price suggests a potential upside of 12.96% from the stock’s current price.
Leave a Reply